Eisai
4523.T
#2011
Rank
โ‚น664.89 B
Marketcap
โ‚น2,359
Share price
-0.53%
Change (1 day)
-41.37%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): โ‚น36.20 Billion

According to Eisai's latest financial reports the company's current earnings are โ‚น5.06 Billion. In 2023 the company made an earning of โ‚น44.69 Billion, an increase over its 2022 earnings that were of -โ‚น1.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น36.20 B-18.98%
2023 โ‚น44.69 B-2392.87%
2022 -โ‚น1.95 Billion-103.6%
2021 โ‚น54.15 B-39.52%
2020 โ‚น89.54 B7.3%
2019 โ‚น83.45 B17.23%
2018 โ‚น71.18 B86.06%
2017 โ‚น38.26 B-23.64%
2016 โ‚น50.10 B27.28%
2015 โ‚น39.36 B22.08%
2014 โ‚น32.24 B-46.11%
2013 โ‚น59.84 B-21.67%
2012 โ‚น76.39 B-20.72%
2011 โ‚น96.37 B-8.44%
2010 โ‚น105.25 B18.85%
2009 โ‚น88.56 B